Last10K.com

Kazia Therapeutics Ltd (KZIA) SEC Filing 6-K Foreign Issuer report for the period ending Friday, July 5, 2019

Kazia Therapeutics Ltd

HISTORY TOOLS
CIK: 1075880 Ticker: KZIA

View differences made from one to another to evaluate Kazia Therapeutics Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Kazia Therapeutics Ltd.

Continue

Assess how Kazia Therapeutics Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Kazia Therapeutics Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: KZIA
CIK: 1075880
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001193125-19-189423
Submitted to the SEC: Fri Jul 05 2019 6:31:07 AM EST
Accepted by the SEC: Fri Jul 05 2019
Period: Friday, July 5, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/kzia/0001193125-19-189423.htm